RXL-2TRZ 30mg | Research Peptide | 99%+ Purity | CAS 2023788-19-2 | RemedyX Labs

RXL-2TRZ 30mg — high-purity research peptide with independently verified 99%+ purity and a batch-specific Certificate of Analysis (COA) CAS 2023788-19-2. Available for in-vitro research use from RemedyX Labs. Third-party tested, research use only.

RXL-2TRZ is a synthetic dual GIP/GLP-1 research peptide supplied as a lyophilized powder. It is used in controlled laboratory studies involving dual incretin receptor activity and related metabolic research models. COA may display previous product labeling. Current batches are standardized under RXL-2TRZ. Updated labeling will be reflected in future production runs. Every batch is independently tested by a third-party laboratory to confirm identity and purity, with batch-specific Certificates of Analysis (COA) available for full transparency. For laboratory research use only. Not for human or animal use. Not intended for diagnostic, therapeutic, clinical, or commercial use.